Atlas Trials

A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder

Clinical trial NCT02288325 · COMPLETED

Trial details

NCT number
NCT02288325
Sponsor
Forest Laboratories
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Depressive Disorder, Major
Start date
2014-11-18
Primary completion
2016-09-16
Enrollment
644

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.